Europe
The pharmaceutical company Biogen announced they plan to file for US marketing approval of the potential Alzheimer’s drug, aducanumab.
Low-cost, flexible and dependable automation possibilities open up for any research group
New research from the Karolinska Institute has demonstrated the I-DOT’s capability to facilitate genetic research in cancer diagnostics. The Karolinska Institute in Sweden is at the forefront of cancer research in the world.
The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.
Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome.
Kiadis Pharma N.V. announces the formation of its Scientific Advisory Board comprised of world-leading experts in the field of oncology and cell therapy.
Porton Biopharma Ltd has announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases to advance a next generation intra-nasal anthrax vaccine into the clinical-trial phase.
MorphoSys AG will publish its first nine months’ 2019 results on October 29, 2019 at 10:00pm CET
The Good Food Institute awards $4.5M to fill gaps in plant-based and cultivated meat science in 2019
Despite booming commercial interest in plant-based and cultivated meat, funding for academic research lags behind and the industries face a dearth of the open-access data that will be required to overcome technical hurdles and scale-up to price parity
Regenstrief Institute research scientist Theresa Cullen, M.D., has won a Leading for Impact, Women in Leadership award.
PRESS RELEASES